Clinical and serological features of systemic sclerosis in a Chinese cohort. - Test2 - elhamkhani - TriplyDB

Clinical and serological features of systemic sclerosis in a Chinese cohort.

Clinical and serological features of systemic sclerosis in a Chinese cohort.

http://www.wikidata.org/entity/Q37073717

about

STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.Association of the HLA-DRB1 with scleroderma in Chinese population.Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han Chinese.Pulmonary involvement in systemic sclerosis: A clinical profile.Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population.Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes.Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese.Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma.Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study.Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.Clinical efficacy and safety of bathing with Chinese medicine Taohong Siwu Decoction () for treatment of diffuse cutaneous systemic sclerosis: A randomized, placebo-controlled trial.

P2860

Q33929738-8BEBFB88-40B1-487B-B33D-8A82F6E2A415 Q34129114-4E43BF20-5CDF-44FE-8D76-F36AF020F070 Q34318888-CDEC7C4C-D461-4B11-8AC8-374EC4AF3EB1 Q36701466-F7BB8ACC-6904-4EE8-AFA7-A832F6783FAD Q37460601-49A4410C-30A8-49F5-98C1-F11EE1A662A2 Q37538699-4A632CCF-8FAE-4EAD-9537-AA547A5B1549 Q40176801-CBC6FBA6-6D5B-4D9D-8F76-0402FADF0C78 Q40291320-38238424-F253-4D65-B2A0-7983DA971446 Q40656308-33DDABC4-A848-43D4-B86D-D16BDCE5F2AD Q40809160-9E2DFD07-ED70-4415-813F-4B0FA1EB6479 Q47198646-054BD417-D18E-45E7-84C7-0C1954AE7D4C Q47446383-5D181A28-6552-457A-B153-428F7C224547 Q47811839-E0E4AEB8-1D83-449C-A836-EAD62047B6BE Q48085664-5FE7440D-C361-4469-B7E0-DF44C0012D76 Q50624934-40FE2263-9672-4BA1-AB20-61C5DE701897 Q51137555-A359BCCC-7985-4E61-8EF1-74B4FBF4DD3B

P2860

Clinical and serological features of systemic sclerosis in a Chinese cohort.

http://www.wikidata.org/entity/Q37073717

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 December 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical and serological features of systemic sclerosis in a Chinese cohort.

@en

Clinical and serological features of systemic sclerosis in a Chinese cohort.

@nl

type

label

Clinical and serological features of systemic sclerosis in a Chinese cohort.

@en

Clinical and serological features of systemic sclerosis in a Chinese cohort.

@nl

prefLabel

Clinical and serological features of systemic sclerosis in a Chinese cohort.

@en

Clinical and serological features of systemic sclerosis in a Chinese cohort.

@nl

P1433

Q37073717-F88FB64B-F956-4BA5-8C42-7C38CB37179D

P1476

Q37073717-32991F3C-5263-4AA2-9831-6ECEE4696D0A

P2093

Q37073717-0008B445-8BB5-44E0-81A6-CEA1D910D2DC

Q37073717-0B208AC8-9444-43AC-B75B-FCCB8E485A8B

Q37073717-16E7338F-E2C7-45F7-A79D-13C4DFE95E2E

Q37073717-1CA8B2C2-2344-42AE-9BCD-B520B3142EF1

Q37073717-1F461EDD-7557-45D7-A103-66BC04EDC7EE

Q37073717-3DDB724E-6668-4780-A388-0E41E5342AA6

Q37073717-465134D0-342B-40F1-B695-54F745A5EAC7

Q37073717-47EF0C86-EC6D-424C-99F1-FEBA7EAA90C4

Q37073717-59C9128F-E35C-439C-9E5C-D3ED626A3607

Q37073717-5BA1CED7-17CC-4BF1-A2F2-59A98E9418DF

P2860

Q37073717-1753DAC4-6B7B-4F43-B035-027F3B5843B4

Q37073717-2B48337C-46F0-44D0-8093-DFD2A8F8C106

Q37073717-5ABA9033-AB94-4858-9811-C8FA39C26E67

Q37073717-60ED5685-BB7F-4EAF-BA89-501975C90A61

Q37073717-68BC0096-8958-490D-8866-6F4D57EF0EB8

Q37073717-A5CC7C3C-2EA7-42C4-AE4A-590F2C989857

Q37073717-C4FFB230-B432-4B3F-B8FE-FC3D1B4735E4

Q37073717-C91234F2-8C5C-4F79-9276-E4E82DB7C445

Q37073717-D36EEAF2-D317-4913-A694-57658C3A9FDA

Q37073717-E8B098E8-918E-40C0-9E2F-072917BDA039

P304

Q37073717-BAC131AF-F23E-4ADE-AB79-4686BE6B9C2F

P31

Q37073717-37E145CE-82CD-4730-A9DD-38945B61885D

P356

Q37073717-C618B913-B736-4B31-AAD4-12ECAE109D75

P433

Q37073717-964B8462-C8FA-4BC2-8D86-172F37A09395

P478

Q37073717-6657088B-C1E3-4EF1-92B4-986AD0DE96F8

P577

Q37073717-A52A7086-0ABA-4775-B444-EC03B1760337

P698

Q37073717-1044A3E0-340F-41AE-B448-C360D1855CFD

P932

Q37073717-9ED07F0F-C43C-445F-89B1-1786B50C5C8A

P356

S10067-012-2145-7

P1433

Clinical Rheumatology

P1476

Clinical and serological features of systemic sclerosis in a Chinese cohort.

@en

P2093

Gang Guo

http://www.w3.org/2001/XMLSchema#string

Haiyan Chu

http://www.w3.org/2001/XMLSchema#string

Hejian Zou

http://www.w3.org/2001/XMLSchema#string

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Jiucun Wang

http://www.w3.org/2001/XMLSchema#string

Li Jin

http://www.w3.org/2001/XMLSchema#string

Li Yang

http://www.w3.org/2001/XMLSchema#string

Maureen D Mayes

http://www.w3.org/2001/XMLSchema#string

Rong Xiao

http://www.w3.org/2001/XMLSchema#string

Sarah J Kim

http://www.w3.org/2001/XMLSchema#string

P2860

HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.

A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.

The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.

Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

Autoantibodies in systemic sclerosis.

Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis.

Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.

P304

617-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-012-2145-7

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23271609

http://www.w3.org/2001/XMLSchema#string

P932

3734856

http://www.w3.org/2001/XMLSchema#string